AU637772B2 - Medicament for the treatment of cryptosporidiosis - Google Patents

Medicament for the treatment of cryptosporidiosis Download PDF

Info

Publication number
AU637772B2
AU637772B2 AU45192/89A AU4519289A AU637772B2 AU 637772 B2 AU637772 B2 AU 637772B2 AU 45192/89 A AU45192/89 A AU 45192/89A AU 4519289 A AU4519289 A AU 4519289A AU 637772 B2 AU637772 B2 AU 637772B2
Authority
AU
Australia
Prior art keywords
international
compound
cryptosporidiosis
animal
search
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU45192/89A
Other languages
English (en)
Other versions
AU4519289A (en
Inventor
Victoria Susan Latter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of AU4519289A publication Critical patent/AU4519289A/en
Application granted granted Critical
Publication of AU637772B2 publication Critical patent/AU637772B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU45192/89A 1989-10-16 1989-10-26 Medicament for the treatment of cryptosporidiosis Ceased AU637772B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898923254A GB8923254D0 (en) 1989-10-16 1989-10-16 Medicaments
GB8923254 1989-10-16

Publications (2)

Publication Number Publication Date
AU4519289A AU4519289A (en) 1991-05-16
AU637772B2 true AU637772B2 (en) 1993-06-10

Family

ID=10664644

Family Applications (1)

Application Number Title Priority Date Filing Date
AU45192/89A Ceased AU637772B2 (en) 1989-10-16 1989-10-26 Medicament for the treatment of cryptosporidiosis

Country Status (14)

Country Link
EP (1) EP0496729B1 (da)
JP (1) JPH05502435A (da)
KR (1) KR920703038A (da)
AT (1) ATE107504T1 (da)
AU (1) AU637772B2 (da)
CA (1) CA2001566A1 (da)
DE (1) DE68916443T2 (da)
DK (1) DK50092D0 (da)
GB (1) GB8923254D0 (da)
HU (1) HU208625B (da)
IE (1) IE893450A1 (da)
MC (1) MC2203A1 (da)
WO (1) WO1991005550A1 (da)
ZA (1) ZA898143B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9126874D0 (en) * 1991-12-18 1992-02-19 Wellcome Found Medicaments
GB9224739D0 (en) 1992-11-26 1993-01-13 Wellcome Found Medicaments
GB9226905D0 (en) * 1992-12-24 1993-02-17 Wellcome Found Pharmaceutical preparation
GB9613309D0 (en) * 1996-06-25 1996-08-28 Univ Sheffield Quinone bacterial inhibitors

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0123238A2 (en) * 1983-04-14 1984-10-31 The Wellcome Foundation Limited Naphthoquinone derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8310140D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Antiprotozoal agents

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0123238A2 (en) * 1983-04-14 1984-10-31 The Wellcome Foundation Limited Naphthoquinone derivatives

Also Published As

Publication number Publication date
GB8923254D0 (en) 1989-12-06
EP0496729A1 (en) 1992-08-05
DE68916443D1 (de) 1994-07-28
JPH05502435A (ja) 1993-04-28
DE68916443T2 (de) 1994-12-22
WO1991005550A1 (en) 1991-05-02
MC2203A1 (fr) 1992-11-26
HUT60431A (en) 1992-09-28
HU208625B (en) 1993-12-28
CA2001566A1 (en) 1991-04-16
ATE107504T1 (de) 1994-07-15
KR920703038A (ko) 1992-12-17
EP0496729B1 (en) 1994-06-22
DK50092A (da) 1992-04-14
HU9201295D0 (en) 1992-07-28
IE893450A1 (en) 1991-04-24
ZA898143B (en) 1991-06-26
DK50092D0 (da) 1992-04-14
AU4519289A (en) 1991-05-16

Similar Documents

Publication Publication Date Title
AP111A (en) Medicaments.
CA1329621C (en) Naphthoquinones in the treatment or prophylaxis of pneumocystis carinii infections
AU637772B2 (en) Medicament for the treatment of cryptosporidiosis
EP0572615B1 (en) Medicament for the Treatment of Protozoal Infections caused by Babesia
US5856362A (en) Medicaments for the treatment of toxoplasmosis
EP0445141B1 (en) Medicaments for the treatment of toxoplasmosis
US6291488B1 (en) Preventing protozoal infections
US5559156A (en) Method for treating animals infected with Babesia spp.
AU676687B2 (en) Use of 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1, 4-naphthoquinone for the treatment of cancer
EP0567162A1 (en) Medicaments for the treatment of toxoplasmosis